{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:56:53Z","timestamp":1792364213175,"version":"4.4.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07692-3","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:24:20Z","timestamp":1772094260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cross-kingdom microbial interactions in the gut during inflammatory bowel disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Liwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijiu","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiang","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiean","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"7692_CR1","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/ecco-jcc\/jjae082","volume":"18","author":"B Caron","year":"2024","unstructured":"Caron B, Honap S, Peyrin-Biroulet L. Epidemiology of inflammatory bowel disease across the ages in the era of advanced therapies. J. Crohns Colitis. 2024;18:ii3\u2013ii15.","journal-title":"J. Crohns Colitis"},{"key":"7692_CR2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/ueg2.12317","volume":"10","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, Jess T. Implications of the changing epidemiology of inflammatory bowel disease in a changing world. U Eur Gastroenterol J. 2022;10:1113\u201320.","journal-title":"U Eur Gastroenterol J"},{"key":"7692_CR3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/ibd\/izaa341","volume":"27","author":"MY Stulman","year":"2021","unstructured":"Stulman MY, et al. Epidemiology of inflammatory bowel diseases in Israel: a nationwide epi-Israeli IBD research nucleus study. Inflamm. Bowel Dis. 2021;27:1784\u201394.","journal-title":"Inflamm. Bowel Dis"},{"key":"7692_CR4","doi-asserted-by":"crossref","unstructured":"Zhornitskiy A, Zhornitsky F, Rasheed W, Mao EJ. Epidemiology and clinical outcomes of hospitalized Hispanic patients with IBD: results of a large national cohort study. Int J Colorectal Dis. 2025;40(41).","DOI":"10.1007\/s00384-025-04822-z"},{"key":"7692_CR5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5217\/ir.2023.00085","volume":"22","author":"U Arora","year":"2024","unstructured":"Arora U, Kedia S, Ahuja V. The practice of fecal microbiota transplantation in inflammatory bowel disease. Intest Res. 2024;22:44\u201364.","journal-title":"Intest Res"},{"key":"7692_CR6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, et al. ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment. J Crohns Colitis. 2020;14:4\u201322.","journal-title":"J Crohns Colitis"},{"key":"7692_CR7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1053\/j.gastro.2024.10.001","volume":"167","author":"S Singh","year":"2024","unstructured":"Singh S, et al. AGA living clinical practice guideline on pharmacological management of moderate-to-severe ulcerative colitis. Gastroenterology. 2024;167:1307\u201343.","journal-title":"Gastroenterology"},{"key":"7692_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11551","volume":"489","author":"CL Maynard","year":"2012","unstructured":"Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 2012;489:231\u201341.","journal-title":"Nature"},{"key":"7692_CR9","doi-asserted-by":"publisher","first-page":"aad5872","DOI":"10.1126\/science.aad5872","volume":"351","author":"JK Pfeiffer","year":"2016","unstructured":"Pfeiffer JK, Virgin HW. Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine. Science. 2016;351:aad5872. https:\/\/doi.org\/10.1126\/science.aad5872.","journal-title":"Science"},{"key":"7692_CR10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/myc.13238","volume":"64","author":"A Beheshti-Maal","year":"2021","unstructured":"Beheshti-Maal A, et al. Gut mycobiome: the probable determinative role of fungi in IBD patients. Mycoses. 2021;64:468\u201376.","journal-title":"Mycoses"},{"key":"7692_CR11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2012.152","volume":"9","author":"C Manichanh","year":"2012","unstructured":"Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9:599\u2013608.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7692_CR12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","volume":"17","author":"M Schirmer","year":"2019","unstructured":"Schirmer M, Garner A, Vlamakis H, Xavier RJ. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol. 2019;17:497\u2013511.","journal-title":"Nat Rev Microbiol"},{"key":"7692_CR13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith PM, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569\u201373.","journal-title":"Science"},{"key":"7692_CR14","doi-asserted-by":"crossref","first-page":"14691","DOI":"10.1073\/pnas.1005963107","volume":"107","author":"C De Filippo","year":"2010","unstructured":"De Filippo C, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107:14691\u201396.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7692_CR15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17:662\u201371.","journal-title":"Cell Host Microbe"},{"key":"7692_CR16","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","volume":"57","author":"H-B Wang","year":"2012","unstructured":"Wang H-B, Wang P-Y, Wang X, Wan Y-L, Liu Y-C. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci. 2012;57:3126\u201335.","journal-title":"Dig Dis Sci"},{"key":"7692_CR17","doi-asserted-by":"crossref","unstructured":"Zheng L, et al. Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of Claudin-2. J Immunol Baltim Md 1950. 2017;199:2976\u201384.","DOI":"10.4049\/jimmunol.1700105"},{"key":"7692_CR18","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1074\/jbc.M211609200","volume":"278","author":"AJ Brown","year":"2003","unstructured":"Brown AJ, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312\u201319.","journal-title":"J Biol Chem"},{"key":"7692_CR19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh N, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40:128\u201339.","journal-title":"Immunity"},{"key":"7692_CR20","doi-asserted-by":"crossref","unstructured":"Ms I, et al. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology. 2000;118.","DOI":"10.1016\/S0016-5085(00)70142-9"},{"key":"7692_CR21","doi-asserted-by":"crossref","first-page":"37944","DOI":"10.1038\/srep37944","volume":"6","author":"E Ciarlo","year":"2016","unstructured":"Ciarlo E, et al. Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo. Sci Rep. 2016;6:37944.","journal-title":"Sci Rep"},{"key":"7692_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2249.2003.02056.x","volume":"131","author":"U B\u00f6cker","year":"2003","unstructured":"B\u00f6cker U, et al. Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin Exp Immunol. 2003;131:53\u201360.","journal-title":"Clin Exp Immunol"},{"key":"7692_CR23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5551\/jat.15065","volume":"20","author":"H Ohira","year":"2013","unstructured":"Ohira H, et al. Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages. J Atheroscler Thromb. 2013;20:425\u201342.","journal-title":"J Atheroscler Thromb"},{"key":"7692_CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4110\/in.2014.14.6.277","volume":"14","author":"CH Kim","year":"2014","unstructured":"Kim CH, Park J, Kim M. Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw. 2014;14:277\u201388.","journal-title":"Immune Netw"},{"key":"7692_CR25","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","volume":"52","author":"LEM Willemsen","year":"2003","unstructured":"Willemsen LEM, Koetsier MA, van Deventer SJH, van Tol EAF. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut. 2003;52:1442\u201347.","journal-title":"Gut"},{"key":"7692_CR26","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1038\/ncomms7734","volume":"6","author":"L Macia","year":"2015","unstructured":"Macia L, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun. 2015;6:6734.","journal-title":"Nat Commun"},{"key":"7692_CR27","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1038\/s41467-018-06048-w","volume":"9","author":"H Fujiwara","year":"2018","unstructured":"Fujiwara H, et al. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun. 2018;9:3674.","journal-title":"Nat Commun"},{"key":"7692_CR28","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 2014;111:2247\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7692_CR29","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.1038\/s41598-018-32860-x","volume":"8","author":"M Luu","year":"2018","unstructured":"Luu M, et al. Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. Sci Rep. 2018;8:14430.","journal-title":"Sci Rep"},{"key":"7692_CR30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"key":"7692_CR31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451\u201355.","journal-title":"Nature"},{"key":"7692_CR32","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307913","volume":"64","author":"ES Chambers","year":"2015","unstructured":"Chambers ES, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64:1744\u201354.","journal-title":"Gut"},{"key":"7692_CR33","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol H, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7692_CR34","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63:1275\u201383.","journal-title":"Gut"},{"key":"7692_CR35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/biom15071017","volume":"15","author":"L Chulenbayeva","year":"2025","unstructured":"Chulenbayeva L, Jarmukhanov Z, Kaliyekova K, Kozhakhmetov S, Kushugulova A. Quantitative alterations in short-chain fatty acids in inflammatory bowel disease: a systematic review and meta-analysis. Biomolecules. 2025;15:1017.","journal-title":"Biomolecules"},{"key":"7692_CR36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ibd\/izx029","volume":"24","author":"P Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves P, Ara\u00fajo JR, Di Santo JP. A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:558\u201372.","journal-title":"Inflamm Bowel Dis"},{"key":"7692_CR37","first-page":"648","volume":"51","author":"A Altomare","year":"2019","unstructured":"Altomare A, et al. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2019;51:648\u201356.","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"7692_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0016-5085(92)91094-K","volume":"103","author":"W Scheppach","year":"1992","unstructured":"Scheppach W, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992;103:51\u201356.","journal-title":"Gastroenterology"},{"key":"7692_CR39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2036.1996.d01-509.x","volume":"10","author":"AH Steinhart","year":"1996","unstructured":"Steinhart AH, Hiruki T, Brzezinski A, Baker JP. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther. 1996;10:729\u201336.","journal-title":"Aliment Pharmacol Ther"},{"key":"7692_CR40","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.3390\/jcm9123941","volume":"9","author":"M Vernero","year":"2020","unstructured":"Vernero M, et al. The usefulness of microencapsulated sodium butyrate add-on therapy in maintaining remission in patients with ulcerative colitis: a prospective observational study. J Clin Med. 2020;9:3941.","journal-title":"J Clin Med"},{"key":"7692_CR41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12944-024-02203-z","volume":"23","author":"D Firoozi","year":"2024","unstructured":"Firoozi D, et al. Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial. Lipids Health Dis. 2024;23:216.","journal-title":"Lipids Health Dis"},{"key":"7692_CR42","first-page":"e21552","volume":"35","author":"EE Alexeev","year":"2021","unstructured":"Alexeev EE, et al. Microbial-derived indoles inhibit neutrophil myeloperoxidase to diminish bystander tissue damage. FASEB J off Publ Fed Am Soc Exp Biol. 2021;35:e21552.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"7692_CR43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/nu15010151","volume":"15","author":"H Jiang","year":"2022","unstructured":"Jiang H, Chen C, Gao J. Extensive summary of the important roles of indole propionic acid, a gut microbial metabolite in host health and disease. Nutrients. 2022;15:151.","journal-title":"Nutrients"},{"key":"7692_CR44","doi-asserted-by":"crossref","first-page":"2467235","DOI":"10.1080\/19490976.2025.2467235","volume":"17","author":"H Gao","year":"2025","unstructured":"Gao H, et al. Microbiota-derived IPA alleviates intestinal mucosal inflammation through upregulating Th1\/Th17 cell apoptosis in inflammatory bowel disease. Gut Microbes. 2025;17:2467235.","journal-title":"Gut Microbes"},{"key":"7692_CR45","doi-asserted-by":"crossref","first-page":"127392","DOI":"10.1016\/j.micres.2023.127392","volume":"272","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Indole metabolites and colorectal cancer: gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms. Microbiol Res. 2023;272:127392.","journal-title":"Microbiol Res"},{"key":"7692_CR46","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/ijms21051579","volume":"21","author":"Y Ji","year":"2020","unstructured":"Ji Y, et al. Anti-inflammatory and anti-oxidative activity of indole-3-acetic acid involves induction of HO-1 and neutralization of free radicals in RAW264.7 cells. Int J Mol Sci. 2020;21:1579.","journal-title":"Int J Mol Sci"},{"key":"7692_CR47","doi-asserted-by":"crossref","unstructured":"Xiao H-W, et al. Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein. Microbiome. 2020;8(69).","DOI":"10.1186\/s40168-020-00845-6"},{"key":"7692_CR48","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ajpath.2018.01.011","volume":"188","author":"EE Alexeev","year":"2018","unstructured":"Alexeev EE, et al. Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of interleukin-10 receptor. Am J Pathol. 2018;188:1183\u201394.","journal-title":"Am J Pathol"},{"key":"7692_CR49","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.it.2018.10.010","volume":"39","author":"R Shinde","year":"2018","unstructured":"Shinde R, McGaha TL. The aryl hydrocarbon receptor: connecting immunity to the microenvironment. Trends Immunol. 2018;39:1005\u201320.","journal-title":"Trends Immunol"},{"key":"7692_CR50","first-page":"902","volume":"85","author":"MMI Chowdhury","year":"2021","unstructured":"Chowdhury MMI, et al. Suppression of TNF\u03b1 expression induced by indole-3-acetic acid is not mediated by AhR activation in Caco-2 cells. Biosci Biotechnol Biochem. 2021;85:902\u201306.","journal-title":"Biosci Biotechnol Biochem"},{"key":"7692_CR51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39:372\u201385.","journal-title":"Immunity"},{"key":"7692_CR52","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.2147\/JIR.S432747","volume":"16","author":"M Wang","year":"2023","unstructured":"Wang M, Guo J, Hart AL, Li JV. Indole-3-aldehyde reduces inflammatory responses and restores intestinal epithelial barrier function partially via aryl hydrocarbon receptor (AhR) in experimental colitis models. J Inflamm Res. 2023;16:5845\u201364.","journal-title":"J Inflamm Res"},{"key":"7692_CR53","doi-asserted-by":"crossref","unstructured":"X Y, et al. Dual role of indoles derived from intestinal microbiota on human health. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.903526"},{"key":"7692_CR54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143\u201348.","journal-title":"Nature"},{"key":"7692_CR55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","volume":"30","author":"J Cai","year":"2022","unstructured":"Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 2022;30:289\u2013300.","journal-title":"Cell Host Microbe"},{"key":"7692_CR56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","volume":"62","author":"H Duboc","year":"2013","unstructured":"Duboc H, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62:531\u201339.","journal-title":"Gut"},{"key":"7692_CR57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","volume":"581","author":"C Campbell","year":"2020","unstructured":"Campbell C, et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature. 2020;581:475\u201379.","journal-title":"Nature"},{"key":"7692_CR58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha SR, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27:659\u201370.e5.","journal-title":"Cell Host Microbe"},{"key":"7692_CR59","doi-asserted-by":"crossref","unstructured":"Fleishman JS, Kumar S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9(97).","DOI":"10.1038\/s41392-024-01811-6"},{"key":"7692_CR60","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.3748\/wjg.v29.i27.4252","volume":"29","author":"X-Q Long","year":"2023","unstructured":"Long X-Q, et al. Bile acids and their receptors: potential therapeutic targets in inflammatory bowel disease. World J Gastroenterol. 2023;29:4252\u201370.","journal-title":"World J Gastroenterol"},{"key":"7692_CR61","doi-asserted-by":"crossref","first-page":"1016836","DOI":"10.3389\/fphar.2022.1016836","volume":"13","author":"M Zhou","year":"2022","unstructured":"Zhou M, et al. Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer. Front Pharmacol. 2022;13:1016836.","journal-title":"Front Pharmacol"},{"key":"7692_CR62","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bbrc.2017.06.129","volume":"490","author":"H-M Liu","year":"2017","unstructured":"Liu H-M, Liao J-F, Lee T-Y. Farnesoid X receptor agonist GW4064 ameliorates lipopolysaccharide-induced ileocolitis through TLR4\/MyD88 pathway related mitochondrial dysfunction in mice. Biochem Biophys Res Commun. 2017;490:841\u201348.","journal-title":"Biochem Biophys Res Commun"},{"key":"7692_CR63","doi-asserted-by":"crossref","first-page":"e170428","DOI":"10.1172\/jci.insight.170428","volume":"9","author":"X Dong","year":"2024","unstructured":"Dong X, et al. Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer progression. JCI Insight. 2024;9:e170428.","journal-title":"JCI Insight"},{"key":"7692_CR64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/imm.13672","volume":"170","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Effect of gut flora mediated-bile acid metabolism on intestinal immune microenvironment. Immunology. 2023;170:301\u201318.","journal-title":"Immunology"},{"key":"7692_CR65","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.3390\/biomedicines12122910","volume":"12","author":"SH Bai","year":"2024","unstructured":"Bai SH, Chandnani A, Cao S. Bile acids in inflammatory bowel disease: from pathophysiology to treatment. Biomedicines. 2024;12:2910.","journal-title":"Biomedicines"},{"key":"7692_CR66","doi-asserted-by":"crossref","first-page":"2323231","DOI":"10.1080\/19490976.2024.2323231","volume":"16","author":"W Chen","year":"2024","unstructured":"Chen W, et al. Bile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease. Gut Microbes. 2024;16:2323231.","journal-title":"Gut Microbes"},{"key":"7692_CR67","doi-asserted-by":"crossref","first-page":"2190300","DOI":"10.1080\/19490976.2023.2190300","volume":"15","author":"Y-H Wei","year":"2023","unstructured":"Wei Y-H, Ma X, Zhao J-C, Wang X-Q, Gao C-Q. Succinate metabolism and its regulation of host-microbe interactions. Gut Microbes. 2023;15:2190300.","journal-title":"Gut Microbes"},{"key":"7692_CR68","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2020.08.029","volume":"159","author":"A Banerjee","year":"2020","unstructured":"Banerjee A, et al. Succinate produced by intestinal microbes promotes specification of tuft cells to suppress ileal inflammation. Gastroenterology. 2020;159:2101\u201315.e5.","journal-title":"Gastroenterology"},{"key":"7692_CR69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2018.05.014","volume":"174","author":"C Schneider","year":"2018","unstructured":"Schneider C, et al. A metabolite-triggered tuft cell-ILC2 circuit drives small intestinal remodeling. Cell. 2018;174:271\u201384.e14.","journal-title":"Cell"},{"key":"7692_CR70","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41419-024-07149-9","volume":"15","author":"K Vlajic","year":"2024","unstructured":"Vlajic K, Bie W, Gilic MB, Tyner AL. Impaired activation of succinate-induced type 2 immunity and secretory cell production in the small intestines of Ptk6-\/- male mice. Cell Death Dis. 2024;15:777.","journal-title":"Cell Death Dis"},{"key":"7692_CR71","doi-asserted-by":"crossref","first-page":"1404441","DOI":"10.3389\/fimmu.2024.1404441","volume":"15","author":"H Huang","year":"2024","unstructured":"Huang H, et al. Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention. Front Immunol. 2024;15:1404441.","journal-title":"Front Immunol"},{"key":"7692_CR72","doi-asserted-by":"crossref","unstructured":"Dalal R, et al. Gut commensals-derived succinate impels colonic inflammation in ulcerative colitis. NPJ Biofilms Microbiomes. 2025;11(44).","DOI":"10.1038\/s41522-025-00672-3"},{"key":"7692_CR73","doi-asserted-by":"crossref","unstructured":"Connors J, Dawe N, Van Limbergen J. The role of succinate in the regulation of intestinal inflammation. Nutrients. 2018;11(25).","DOI":"10.3390\/nu11010025"},{"key":"7692_CR74","doi-asserted-by":"crossref","first-page":"109521","DOI":"10.1016\/j.celrep.2021.109521","volume":"36","author":"M Fremder","year":"2021","unstructured":"Fremder M, et al. A transepithelial pathway delivers succinate to macrophages, thus perpetuating their pro-inflammatory metabolic state. Cell Rep. 2021;36:109521.","journal-title":"Cell Rep"},{"key":"7692_CR75","doi-asserted-by":"crossref","first-page":"C440","DOI":"10.1152\/ajpcell.00411.2025","volume":"329","author":"L Huo","year":"2025","unstructured":"Huo L, et al. Gut microbiome promotes succinate-induced ulcerative colitis by enhancing glycolysis through SUCNR1\/NF-\u03baB signaling pathway. Am. J. Physiol. Cell Physiol. 2025;329:C440\u201354.","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"7692_CR76","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/biomedicines10030532","volume":"10","author":"C Bauset","year":"2022","unstructured":"Bauset C, et al. SUCNR1 mediates the priming step of the Inflammasome in intestinal epithelial cells: relevance in ulcerative colitis. Biomedicines. 2022;10:532.","journal-title":"Biomedicines"},{"key":"7692_CR77","doi-asserted-by":"crossref","first-page":"111389","DOI":"10.1016\/j.celrep.2022.111389","volume":"40","author":"Y Guo","year":"2022","unstructured":"Guo Y, et al. Targeting the succinate receptor effectively inhibits periodontitis. Cell Rep. 2022;40:111389.","journal-title":"Cell Rep"},{"key":"7692_CR78","doi-asserted-by":"crossref","first-page":"1630310","DOI":"10.3389\/fimmu.2025.1630310","volume":"16","author":"M Dai","year":"2025","unstructured":"Dai M, Bu S, Miao Z. Succinate metabolism: underlying biological mechanisms and emerging therapeutic targets in inflammatory bowel disease. Front Immunol. 2025;16:1630310.","journal-title":"Front Immunol"},{"key":"7692_CR79","doi-asserted-by":"crossref","first-page":"102599","DOI":"10.1016\/j.mib.2025.102599","volume":"85","author":"S Fern\u00e1ndez-Veledo","year":"2025","unstructured":"Fern\u00e1ndez-Veledo S, Grau-Bov\u00e9 C, Notararigo S, Huber-Ruano I. The role of microbial succinate in the pathophysiology of inflammatory bowel disease: mechanisms and therapeutic potential. Curr Opin Microbiol. 2025;85:102599.","journal-title":"Curr Opin Microbiol"},{"key":"7692_CR80","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mucimm.2022.11.001","volume":"16","author":"M Michaels","year":"2023","unstructured":"Michaels M, Madsen KL. Immunometabolism and microbial metabolites at the gut barrier: lessons for therapeutic intervention in inflammatory bowel disease. Mucosal Immunol. 2023;16:72\u201385.","journal-title":"Mucosal Immunol"},{"key":"7692_CR81","doi-asserted-by":"crossref","first-page":"101350","DOI":"10.1016\/j.jcmgh.2024.04.007","volume":"18","author":"B Bao","year":"2024","unstructured":"Bao B, et al. Bacterial sphingolipids exacerbate colitis by inhibiting ILC3-derived IL-22 production. Cell Mol Gastroenterol Hepatol. 2024;18:101350.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"7692_CR82","first-page":"9890141","volume":"2016","author":"P-F Bryan","year":"2016","unstructured":"Bryan P-F, et al. Sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: implications for inflammatory bowel disease. Mediators Inflamm. 2016;2016:9890141.","journal-title":"Mediators Inflamm"},{"key":"7692_CR83","doi-asserted-by":"crossref","first-page":"598232","DOI":"10.3389\/fmicb.2021.598232","volume":"12","author":"HEF Becker","year":"2021","unstructured":"Becker HEF, et al. Higher prevalence of Bacteroides fragilis in Crohn\u2019s disease exacerbations and strain-dependent increase of epithelial resistance. Front Microbiol. 2021;12:598232.","journal-title":"Front Microbiol"},{"key":"7692_CR84","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/nu16070937","volume":"16","author":"L Vesci","year":"2024","unstructured":"Vesci L, et al. A novel Lactobacillus brevis fermented with a vegetable substrate (AL0035) counteracts TNBS-Induced colitis by modulating the gut microbiota composition and intestinal barrier. Nutrients. 2024;16:937.","journal-title":"Nutrients"},{"key":"7692_CR85","doi-asserted-by":"crossref","first-page":"e09725","DOI":"10.1016\/j.heliyon.2022.e09725","volume":"8","author":"BA Tegegne","year":"2022","unstructured":"Tegegne BA, Kebede B. Probiotics, their prophylactic and therapeutic applications in human health development: a review of the literature. Heliyon. 2022;8:e09725.","journal-title":"Heliyon"},{"key":"7692_CR86","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/ibd\/izad289","volume":"30","author":"I Catal\u00e1n-Serra","year":"2024","unstructured":"Catal\u00e1n-Serra I, et al. Fungal microbiota composition in inflammatory bowel disease patients: characterization in different phenotypes and correlation with clinical activity and disease course. Inflamm Bowel Dis. 2024;30:1164\u201377.","journal-title":"Inflamm Bowel Dis"},{"key":"7692_CR87","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41385-022-00536-5","volume":"15","author":"M Swidergall","year":"2022","unstructured":"Swidergall M, LeibundGut-Landmann S. Immunosurveillance of Candida albicans commensalism by the adaptive immune system. Mucosal Immunol. 2022;15:829\u201336.","journal-title":"Mucosal Immunol"},{"key":"7692_CR88","doi-asserted-by":"crossref","first-page":"100036","DOI":"10.1016\/j.jtauto.2020.100036","volume":"3","author":"M Di Paola","year":"2020","unstructured":"Di Paola M, et al. Comparative immunophenotyping of Saccharomyces cerevisiae and Candida spp. strains from Crohn\u2019s disease patients and their interactions with the gut microbiome. J Transl Autoimmun. 2020;3:100036.","journal-title":"J Transl Autoimmun"},{"key":"7692_CR89","doi-asserted-by":"crossref","unstructured":"Nenciarini S, et al. Impact of cooperative or competitive dynamics between the yeast Saccharomyces cerevisiae and lactobacilli on the immune response of the host. Front Immunol. 2024;15.","DOI":"10.3389\/fimmu.2024.1399842"},{"key":"7692_CR90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/pathogens14040313","volume":"14","author":"O Pawelec-P\u0119ciak","year":"2025","unstructured":"Pawelec-P\u0119ciak O, \u0141anocha-Arendarczyk N, Grzeszczak K, Kosik-Bogacka D. The role of Blastocystis spp. In the etiology of gastrointestinal and autoimmune diseases. Pathog Basel Switz. 2025;14:313.","journal-title":"Pathog Basel Switz"},{"key":"7692_CR91","doi-asserted-by":"crossref","unstructured":"Deng L, et al. Colonization with ubiquitous protist Blastocystis ST1 ameliorates DSS-induced colitis and promotes beneficial microbiota and immune outcomes. NPJ Biofilms Microbiomes. 2023;9(22).","DOI":"10.1038\/s41522-023-00389-1"},{"key":"7692_CR92","doi-asserted-by":"crossref","unstructured":"Li X, et al. A novel TLR4-binding domain of peroxiredoxin from Entamoeba histolytica triggers NLRP3 inflammasome activation in macrophages. Front. Immunol. 2021;12.","DOI":"10.3389\/fimmu.2021.758451"},{"key":"7692_CR93","doi-asserted-by":"crossref","first-page":"1430057","DOI":"10.3389\/fimmu.2024.1430057","volume":"15","author":"D Dong","year":"2024","unstructured":"Dong D, et al. The macrophage polarization in Entamoeba histolytica infection modulation by the C fragment of the intermediate subunit of Gal\/GalNAc-inhibitable lectin. Front Immunol. 2024;15:1430057.","journal-title":"Front Immunol"},{"key":"7692_CR94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature17625","volume":"532","author":"DL Moyes","year":"2016","unstructured":"Moyes DL, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature. 2016;532:64\u201368.","journal-title":"Nature"},{"key":"7692_CR95","doi-asserted-by":"crossref","first-page":"666900","DOI":"10.3389\/fcimb.2021.666900","volume":"11","author":"A Fusco","year":"2021","unstructured":"Fusco A, Savio V, Donniacuo M, Perfetto B, Donnarumma G. Antimicrobial peptides human beta-defensin-2 and -3 protect the gut during Candida albicans infections enhancing the intestinal barrier integrity: In Vitro study. Front Cell Infect Microbiol. 2021;11:666900.","journal-title":"Front Cell Infect Microbiol"},{"key":"7692_CR96","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.micres.2013.02.008","volume":"168","author":"L Yan","year":"2013","unstructured":"Yan L, Yang C, Tang J. Disruption of the intestinal mucosal barrier in Candida albicans infections. Microbiol Res. 2013;168:389\u201395.","journal-title":"Microbiol Res"},{"key":"7692_CR97","doi-asserted-by":"crossref","first-page":"e02142","DOI":"10.1128\/mBio.02142-16","volume":"8","author":"E Klaile","year":"2017","unstructured":"Klaile E, et al. Binding of Candida albicans to human CEACAM1 and CEACAM6 modulates the inflammatory response of intestinal epithelial cells. mBio. 2017;8:e02142\u201316.","journal-title":"mBio"},{"key":"7692_CR98","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.pt.2017.08.005","volume":"33","author":"M Chab\u00e9","year":"2017","unstructured":"Chab\u00e9 M, Lokmer A, S\u00e9gurel L. Gut Protozoa: Friends or foes of the human Gut microbiota? Trends Parasitol. 2017;33:925\u201334.","journal-title":"Trends Parasitol"},{"key":"7692_CR99","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/jof9111105","volume":"9","author":"SL Carlson","year":"2023","unstructured":"Carlson SL, et al. Mucosal immunity to gut fungi in health and inflammatory bowel disease. J Fungi Basel Switz. 2023;9:1105.","journal-title":"J Fungi Basel Switz"},{"key":"7692_CR100","doi-asserted-by":"crossref","unstructured":"Wang F, Wang Z, Tang J. The interactions of Candida albicans with gut bacteria: a new strategy to prevent and treat invasive intestinal candidiasis. Gut Pathog. 2023;15(30).","DOI":"10.1186\/s13099-023-00559-8"},{"key":"7692_CR101","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41586-024-07142-4","volume":"627","author":"S-H Liang","year":"2024","unstructured":"Liang S-H, et al. The hyphal-specific toxin candidalysin promotes fungal gut commensalism. Nature. 2024;627:620\u201327.","journal-title":"Nature"},{"key":"7692_CR102","doi-asserted-by":"crossref","first-page":"fiz187","DOI":"10.1093\/femsec\/fiz187","volume":"96","author":"D Gutierrez","year":"2020","unstructured":"Gutierrez D, et al. Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract. FEMS Microbiol. Ecol. 2020;96:fiz187.","journal-title":"FEMS Microbiol. Ecol"},{"key":"7692_CR103","doi-asserted-by":"crossref","first-page":"e1007717","DOI":"10.1371\/journal.ppat.1007717","volume":"15","author":"M Bertolini","year":"2019","unstructured":"Bertolini M, et al. Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection. PLoS Pathog. 2019;15:e1007717.","journal-title":"PLoS Pathog"},{"key":"7692_CR104","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.3748\/wjg.v30.i48.5212","volume":"30","author":"S Patnaik","year":"2024","unstructured":"Patnaik S, et al. Role of Candida species in pathogenesis, immune regulation, and prognostic tools for managing ulcerative colitis and Crohn\u2019s disease. World J Gastroenterol. 2024;30:5212\u201320.","journal-title":"World J Gastroenterol"},{"key":"7692_CR105","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/528990","volume":"197","author":"S Jawhara","year":"2008","unstructured":"Jawhara S, et al. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis. 2008;197:972\u201380.","journal-title":"J Infect Dis"},{"key":"7692_CR106","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/ajg.2009.225","volume":"104","author":"A Standaert-Vitse","year":"2009","unstructured":"Standaert-Vitse A, et al. Candida albicans colonization and ASCA in familial Crohn\u2019s disease. Am J Gastroenterol. 2009;104:1745\u201353.","journal-title":"Am J Gastroenterol"},{"key":"7692_CR107","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/ajg.2011.304","volume":"106","author":"SY Shaw","year":"2011","unstructured":"Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn\u2019s disease and ulcerative colitis. Am J Gastroenterol. 2011;106:2133\u201342.","journal-title":"Am J Gastroenterol"},{"key":"7692_CR108","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1073\/pnas.1620432114","volume":"114","author":"CE Graham","year":"2017","unstructured":"Graham CE, Cruz MR, Garsin DA, Lorenz MC. Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc Natl Acad Sci USA. 2017;114:4507\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7692_CR109","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.gastro.2016.10.018","volume":"152","author":"C Abraham","year":"2017","unstructured":"Abraham C, Dulai PS, Vermeire S, Sandborn WJ. Lessons learned from trials Targeting cytokine pathways in patients with inflammatory bowel diseases. Gastroenterology. 2017;152:374\u201388.e4.","journal-title":"Gastroenterology"},{"key":"7692_CR110","doi-asserted-by":"crossref","first-page":"812148","DOI":"10.3389\/fimmu.2022.812148","volume":"13","author":"P Mata-Mart\u00ednez","year":"2022","unstructured":"Mata-Mart\u00ednez P, Berg\u00f3n-Guti\u00e9rrez M, Del Fresno C. Dectin-1 signaling update: new perspectives for trained immunity. Front Immunol. 2022;13:812148.","journal-title":"Front Immunol"},{"key":"7692_CR111","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1221789","volume":"336","author":"ID Iliev","year":"2012","unstructured":"Iliev ID, et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science. 2012;336:1314\u201317.","journal-title":"Science"},{"key":"7692_CR112","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jcmm.14770","volume":"24","author":"P Luo","year":"2020","unstructured":"Luo P, Yang Z, Chen B, Zhong X. The multifaceted role of CARD9 in inflammatory bowel disease. J Cell Mol Med. 2020;24:34\u201339.","journal-title":"J Cell Mol Med"},{"key":"7692_CR113","doi-asserted-by":"crossref","first-page":"e1012031","DOI":"10.1371\/journal.ppat.1012031","volume":"20","author":"JL Sprague","year":"2024","unstructured":"Sprague JL, et al. Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NF\u03baB-mediated barrier protection. PLoS Pathog. 2024;20:e1012031.","journal-title":"PLoS Pathog"},{"key":"7692_CR114","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pbio.0050064","volume":"5","author":"QT Phan","year":"2007","unstructured":"Phan QT, et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 2007;5:e64.","journal-title":"PLoS Biol"},{"key":"7692_CR115","doi-asserted-by":"crossref","first-page":"1612661","DOI":"10.1080\/21688370.2019.1612661","volume":"7","author":"L Basmaciyan","year":"2019","unstructured":"Basmaciyan L, Bon F, Paradis T, Lapaquette P, Dalle F. Candida Albicans interactions with the host: crossing the intestinal epithelial barrier. Tissue Barriers. 2019;7:1612661.","journal-title":"Tissue Barriers"},{"key":"7692_CR116","doi-asserted-by":"crossref","unstructured":"Panpetch W, et al. Additional Candida albicans administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by Lactobacillus rhamnosus L34. Gut Microbes. 11:465\u201380.","DOI":"10.1080\/19490976.2019.1662712"},{"key":"7692_CR117","doi-asserted-by":"crossref","first-page":"e01250","DOI":"10.1128\/mBio.01250-16","volume":"7","author":"G Hoarau","year":"2016","unstructured":"Hoarau G, et al. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn\u2019s disease. mBio. 2016;7:e01250\u201316.","journal-title":"mBio"},{"key":"7692_CR118","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","volume":"52","author":"DE Karageorgopoulos","year":"2011","unstructured":"Karageorgopoulos DE, et al. \u03b2-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis off Publ Infect Dis Soc Am. 2011;52:750\u201370.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"7692_CR119","first-page":"107","volume":"60","author":"M Zwolinska-Wcislo","year":"2009","unstructured":"Zwolinska-Wcislo M, et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J Physiol Pharmacol off J Pol Physiol Soc. 2009;60:107\u201318.","journal-title":"J Physiol Pharmacol Off J Pol Physiol Soc"},{"key":"7692_CR120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.chom.2020.03.006","volume":"27","author":"I Leonardi","year":"2020","unstructured":"Leonardi I, et al. Fungal trans-kingdom dynamics linked to responsiveness to fecal microbiota transplantation (FMT) therapy in ulcerative colitis. Cell Host Microbe. 2020;27:823\u20139.e3.","journal-title":"Cell Host Microbe"},{"key":"7692_CR121","doi-asserted-by":"crossref","first-page":"104088","DOI":"10.1016\/j.ebiom.2022.104088","volume":"81","author":"NP Rees","year":"2022","unstructured":"Rees NP, et al. Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis. EBioMedicine. 2022;81:104088.","journal-title":"EBioMedicine"},{"key":"7692_CR122","doi-asserted-by":"crossref","unstructured":"Benech N, Sokol H. Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine. Genome Med. 2020;12(58).","DOI":"10.1186\/s13073-020-00757-y"},{"key":"7692_CR123","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.3390\/ijms24076721","volume":"24","author":"Q Hu","year":"2023","unstructured":"Hu Q, Yu L, Zhai Q, Zhao J, Tian FA-I. Barrier maintenance, and gut microbiome modulation effects of Saccharomyces cerevisiae QHNLD8L1 on DSS-Induced ulcerative colitis in mice. Int J Mol Sci. 2023;24:6721.","journal-title":"Int J Mol Sci"},{"key":"7692_CR124","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol H, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66:1039\u201348.","journal-title":"Gut"},{"key":"7692_CR125","doi-asserted-by":"crossref","first-page":"e18573","DOI":"10.1371\/journal.pone.0018573","volume":"6","author":"G Zanello","year":"2011","unstructured":"Zanello G, et al. Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1\/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One. 2011;6:e18573.","journal-title":"PLoS One"},{"key":"7692_CR126","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2013.00230","volume":"4","author":"N Bose","year":"2013","unstructured":"Bose N, et al. Binding of soluble yeast \u03b2-glucan to human neutrophils and monocytes is complement-dependent. Front Immunol. 2013;4:230.","journal-title":"Front Immunol"},{"key":"7692_CR127","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1038\/s41598-023-33958-7","volume":"13","author":"BJ Kil","year":"2023","unstructured":"Kil BJ, et al. Probiotic potential of Saccharomyces cerevisiae GILA with alleviating intestinal inflammation in a dextran sulfate sodium induced colitis mouse model. Sci Rep. 2023;13:6687.","journal-title":"Sci Rep"},{"key":"7692_CR128","doi-asserted-by":"crossref","first-page":"e60086","DOI":"10.1371\/journal.pone.0060086","volume":"8","author":"SE Elcombe","year":"2013","unstructured":"Elcombe SE, et al. Dectin-1 regulates IL-10 production via a MSK1\/2 and CREB dependent pathway and promotes the induction of regulatory macrophage markers. PLoS One. 2013;8:e60086.","journal-title":"PLoS One"},{"key":"7692_CR129","doi-asserted-by":"crossref","unstructured":"Jin X, Zhang M, Cao G-F, Yang Y-F. Saccharomyces cerevisiae mannan induces sheep beta-defensin-1 expression via Dectin-2-Syk-p38 pathways in ovine ruminal epithelial cells. Vet Res. 2019;50(8).","DOI":"10.1186\/s13567-019-0624-4"},{"key":"7692_CR130","doi-asserted-by":"crossref","unstructured":"Liu M, et al. Dectin-1 activation by a natural product \u03b2-glucan converts immunosuppressive macrophages into an M1-like phenotype. J Immunol Baltim Md 1950. 2015;195:5055\u201365.","DOI":"10.4049\/jimmunol.1501158"},{"key":"7692_CR131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/CEG.S111003","volume":"9","author":"H Stier","year":"2016","unstructured":"Stier H, Bischoff SC. Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system. Clin Exp Gastroenterol. 2016;9:269\u201379.","journal-title":"Clin Exp Gastroenterol"},{"key":"7692_CR132","doi-asserted-by":"crossref","first-page":"894445","DOI":"10.3389\/fimmu.2022.894445","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Zhang R, Li J, Li J. The role of C-Type lectin receptor signaling in the intestinal microbiota-inflammation-cancer axis. Front Immunol. 2022;13:894445.","journal-title":"Front Immunol"},{"key":"7692_CR133","first-page":"1436","volume":"11","author":"Y Meng","year":"2022","unstructured":"Meng Y, et al. Saccharomyces cerevisiae I4 showed alleviating effects on dextran sulfate sodium-induced colitis of Balb\/c mice. Foods Basel Switz. 2022;11:1436.","journal-title":"Foods Basel Switz"},{"key":"7692_CR134","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3748\/wjg.v16.i17.2134","volume":"16","author":"B Folign\u00e9","year":"2010","unstructured":"Folign\u00e9 B, Dewulf J, Vandekerckove P, Pign\u00e8de G, Pot B. Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice. World J Gastroenterol. 2010;16:2134\u201345.","journal-title":"World J Gastroenterol"},{"key":"7692_CR135","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1023\/A:1005588911207","volume":"45","author":"M Guslandi","year":"2000","unstructured":"Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn\u2019s disease. Dig Dis Sci. 2000;45:1462\u201364.","journal-title":"Dig Dis Sci"},{"key":"7692_CR136","first-page":"982","volume":"11","author":"A Bourreille","year":"2013","unstructured":"Bourreille A, et al. Saccharomyces boulardii does not prevent relapse of Crohn\u2019s disease. Clin Gastroenterol Hepatol off Clin Pract J Am Gastroenterol Assoc. 2013;11:982\u201387.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"7692_CR137","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ueg2.12636","volume":"12","author":"MM Estevinho","year":"2024","unstructured":"Estevinho MM, et al. Efficacy and safety of probiotics in IBD: an overview of systematic reviews and updated meta-analysis of randomized controlled trials. U Eur Gastroenterol J. 2024;12:960\u201381.","journal-title":"U Eur Gastroenterol J"},{"key":"7692_CR138","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4166\/kjg.2020.115","volume":"76","author":"GM Oh","year":"2020","unstructured":"Oh GM, et al. Changes in the Crohn\u2019s disease activity index and safety of administering Saccharomyces Boulardii in patients with Crohn\u2019s disease in clinical remission: a single hospital-based retrospective cohort study. Korean J Gastroenterol Taehan Sohwagi Hakhoe Chi. 2020;76:314\u201321.","journal-title":"Korean J Gastroenterol Taehan Sohwagi Hakhoe Chi"},{"key":"7692_CR139","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00042737-200306000-00017","volume":"15","author":"M Guslandi","year":"2003","unstructured":"Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol. 2003;15:697\u201398.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"7692_CR140","first-page":"102342","volume":"17","author":"C-C Yang","year":"2025","unstructured":"Yang C-C, et al. Application of Saccharomyces boulardii in combination with sulfasalazine in ulcerative colitis patients demonstrates significant effectiveness. World J Gastrointest Surg. 2025;17:102342.","journal-title":"World J Gastrointest Surg"},{"key":"7692_CR141","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1219328","volume":"336","author":"T Olszak","year":"2012","unstructured":"Olszak T, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489\u201393.","journal-title":"Science"},{"key":"7692_CR142","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2017.02.011","volume":"139","author":"T Gensollen","year":"2017","unstructured":"Gensollen T, Blumberg RS. Correlation between early-life regulation of the immune system by microbiota and allergy development. J Allergy Clin Immunol. 2017;139:1084\u201391.","journal-title":"J Allergy Clin Immunol"},{"key":"7692_CR143","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.14309\/ajg.0000000000001933","volume":"117","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, et al. Early-life mebendazole exposure increases the risk of adult-onset ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2022;117:2025\u201332.","journal-title":"Am J Gastroenterol"},{"key":"7692_CR144","first-page":"1","volume":"13","author":"W Liu","year":"2021","unstructured":"Liu W, et al. Exposure to soil environments during earlier life stages is distinguishable in the gut microbiome of adult mice. Gut Microbes. 2021;13:1\u201313.","journal-title":"Gut Microbes"},{"key":"7692_CR145","doi-asserted-by":"crossref","first-page":"650621","DOI":"10.3389\/fimmu.2021.650621","volume":"12","author":"AW Arildsen","year":"2021","unstructured":"Arildsen AW, Zachariassen LF, Krych L, Hansen AK, Hansen CHF. Delayed gut colonization shapes future allergic responses in a murine model of atopic dermatitis. Front Immunol. 2021;12:650621.","journal-title":"Front Immunol"},{"key":"7692_CR146","doi-asserted-by":"crossref","first-page":"104615","DOI":"10.1016\/j.micpath.2020.104615","volume":"152","author":"Z Khorshidvand","year":"2021","unstructured":"Khorshidvand Z, Khazaei S, Amiri M, Taherkhani H, Mirzaei A. Worldwide prevalence of emerging parasite Blastocystis in immunocompromised patients: a systematic review and meta-analysis. Microb Pathog. 2021;152:104615.","journal-title":"Microb Pathog"},{"key":"7692_CR147","doi-asserted-by":"crossref","unstructured":"Boutahar M, et al. Prevalence of Blastocystis sp. in morocco: comparative assessment of three diagnostic methods and characterization of parasite forms in Jones\u2019 culture medium. Parasite Paris Fr. 2023;30:6.","DOI":"10.1051\/parasite\/2023065"},{"key":"7692_CR148","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/microorganisms12030461","volume":"12","author":"M Aykur","year":"2024","unstructured":"Aykur M, et al. Blastocystis: a mysterious member of the gut microbiome. Microorganisms. 2024;12:461.","journal-title":"Microorganisms"},{"key":"7692_CR149","doi-asserted-by":"crossref","first-page":"1514587","DOI":"10.3389\/fmed.2025.1514587","volume":"12","author":"Z Khosravany","year":"2025","unstructured":"Khosravany Z, et al. A preliminary study of the association between Blastocystis and quantification of selected yeasts in IBD and IBS patients. Front Med. 2025;12:1514587.","journal-title":"Front Med"},{"key":"7692_CR150","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3109\/00365521.2013.780094","volume":"48","author":"AM Petersen","year":"2013","unstructured":"Petersen AM, et al. Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection. Scand J Gastroenterol. 2013;48:638\u201339.","journal-title":"Scand J Gastroenterol"},{"key":"7692_CR151","doi-asserted-by":"crossref","first-page":"105755","DOI":"10.1016\/j.actatropica.2020.105755","volume":"213","author":"A Toychiev","year":"2021","unstructured":"Toychiev A, et al. Intestinal protozoa and helminths in ulcerative colitis and the influence of anti-parasitic therapy on the course of the disease. Acta Trop. 2021;213:105755.","journal-title":"Acta Trop"},{"key":"7692_CR152","first-page":"100210","volume":"36","author":"NC Panarelli","year":"2023","unstructured":"Panarelli NC. Infectious mimics of inflammatory bowel disease. Mod. Pathol off J US Can Acad Pathol Inc. 2023;36:100210.","journal-title":"Mod. Pathol Off J US Can Acad Pathol Inc"},{"key":"7692_CR153","doi-asserted-by":"crossref","first-page":"e0004879","DOI":"10.1371\/journal.pntd.0004879","volume":"10","author":"D-A Shirley","year":"2016","unstructured":"Shirley D-A, Moonah S. Fulminant Amebic colitis after corticosteroid therapy: a systematic review. PLoS Negl Trop Dis. 2016;10:e0004879.","journal-title":"PLoS Negl Trop Dis"},{"key":"7692_CR154","doi-asserted-by":"crossref","first-page":"641483","DOI":"10.3389\/fmicb.2021.641483","volume":"12","author":"V Billy","year":"2021","unstructured":"Billy V, et al. Blastocystis colonization Alters the gut microbiome and, in some cases, promotes faster recovery from induced colitis. Front Microbiol. 2021;12:641483.","journal-title":"Front Microbiol"},{"key":"7692_CR155","doi-asserted-by":"crossref","first-page":"533528","DOI":"10.3389\/fcimb.2021.533528","volume":"11","author":"G Even","year":"2021","unstructured":"Even G, et al. Changes in the human gut microbiota associated with colonization by Blastocystis sp. and Entamoeba spp. In non-industrialized populations. Front Cell Infect Microbiol. 2021;11:533528.","journal-title":"Front Cell Infect Microbiol"},{"key":"7692_CR156","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.7150\/thno.81583","volume":"13","author":"L Deng","year":"2023","unstructured":"Deng L, et al. Colonization with two different Blastocystis subtypes in DSS-induced colitis mice is associated with strikingly different microbiome and pathological features. Theranostics. 2023;13:1165\u201379.","journal-title":"Theranostics"},{"key":"7692_CR157","doi-asserted-by":"crossref","first-page":"e0226921","DOI":"10.1128\/spectrum.02269-21","volume":"10","author":"L Deng","year":"2022","unstructured":"Deng L, et al. Changes in gut microbiota composition associated with the presence of enteric protist Blastocystis in captive forest musk deer (Moschus Berezovskii). Microbiol Spectr. 2022;10:e0226921.","journal-title":"Microbiol Spectr"},{"key":"7692_CR158","doi-asserted-by":"crossref","unstructured":"Yason JA, Liang YR, Png CW, Zhang Y, Tan KSW. Interactions between a pathogenic Blastocystis subtype and gut microbiota: in vitro and in vivo studies. Microbiome. 2019;7(30).","DOI":"10.1186\/s40168-019-0644-3"},{"key":"7692_CR159","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.4269\/ajtmh.19-0396","volume":"101","author":"Y Yanagawa","year":"2019","unstructured":"Yanagawa Y, et al. Case report: acute amebic colitis triggered by colonoscopy: exacerbation of asymptomatic chronic infection with Entamoeba histolytica accompanied by Dysbiosis. Am J Trop Med Hyg. 2019;101:1384\u201387.","journal-title":"Am J Trop Med Hyg"},{"key":"7692_CR160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/microorganisms9030581","volume":"9","author":"S Ankri","year":"2021","unstructured":"Ankri S. Entamoeba histolytica-gut microbiota interaction: more than meets the eye. Microorganisms. 2021;9:581.","journal-title":"Microorganisms"},{"key":"7692_CR161","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1017\/S0031182016001396","volume":"143","author":"C Nourrisson","year":"2016","unstructured":"Nourrisson C, et al. On Blastocystis secreted cysteine proteases: a legumain-activated cathepsin B increases paracellular permeability of intestinal Caco-2 cell monolayers. Parasitology. 2016;143:1713\u201322.","journal-title":"Parasitology"},{"key":"7692_CR162","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pt.2019.12.008","volume":"36","author":"CR Stensvold","year":"2020","unstructured":"Stensvold CR, Tan KSW, Clark CG. Blastocystis. Trends Parasitol. 2020;36:315\u201316.","journal-title":"Trends Parasitol"},{"key":"7692_CR163","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3389\/fmicb.2015.01394","volume":"6","author":"S Begum","year":"2015","unstructured":"Begum S, Quach J, Chadee K. Immune evasion mechanisms of Entamoeba histolytica: progression to disease. Front Microbiol. 2015;6:1394.","journal-title":"Front Microbiol"},{"key":"7692_CR164","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.3390\/ijms241411755","volume":"24","author":"P Mor\u00e1n","year":"2023","unstructured":"Mor\u00e1n P, et al. Amoebiasis: advances in diagnosis, treatment, Immunology features and the interaction with the intestinal ecosystem. Int J Mol Sci. 2023;24:11755.","journal-title":"Int J Mol Sci"},{"key":"7692_CR165","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2353\/ajpath.2010.090740","volume":"176","author":"SM Becker","year":"2010","unstructured":"Becker SM, et al. Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the gut. Am J Pathol. 2010;176:1316\u201322.","journal-title":"Am J Pathol"},{"key":"7692_CR166","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0016-5085(97)70035-0","volume":"112","author":"Y Yu","year":"1997","unstructured":"Yu Y, Chadee K. Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact. Gastroenterology. 1997;112:1536\u201347.","journal-title":"Gastroenterology"},{"key":"7692_CR167","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JCM.41.1.237-241.2003","volume":"41","author":"P Gonin","year":"2003","unstructured":"Gonin P, Trudel L. Detection and differentiation of Entamoeba histolytica and Entamoeba dispar isolates in clinical samples by PCR and Enzyme-linked immunosorbent assay. J Clin Microbiol. 2003;41:237\u201341.","journal-title":"J Clin Microbiol"},{"key":"7692_CR168","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2229-5070.149887","volume":"5","author":"FMS Oliveira","year":"2015","unstructured":"Oliveira FMS, Neumann E, Gomes MA, Caliari MV. Entamoeba dispar: could it be pathogenic. Trop Parasitol. 2015;5:9\u201314.","journal-title":"Trop Parasitol"},{"key":"7692_CR169","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40168-024-01832-x","volume":"12","author":"X Tian","year":"2024","unstructured":"Tian X, et al. Gut virome-wide association analysis identifies cross-population viral signatures for inflammatory bowel disease. Microbiome. 2024;12:130.","journal-title":"Microbiome"},{"key":"7692_CR170","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gutjnl-2018-318131","volume":"68","author":"T Zuo","year":"2019","unstructured":"Zuo T, et al. Gut mucosal virome alterations in ulcerative colitis. Gut. 2019;68:1169\u201379.","journal-title":"Gut"},{"key":"7692_CR171","doi-asserted-by":"crossref","first-page":"104113","DOI":"10.1016\/j.ebiom.2022.104113","volume":"81","author":"Z Cao","year":"2022","unstructured":"Cao Z, et al. The gut virome: a new microbiome component in health and disease. EBioMedicine. 2022;81:104113.","journal-title":"EBioMedicine"},{"key":"7692_CR172","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature23295","volume":"549","author":"JS Weitz","year":"2017","unstructured":"Weitz JS, Beckett SJ, Brum JR, Cael BB, Dushoff J. Lysis, lysogeny and virus-microbe ratios. Nature. 2017;549:E1\u20133.","journal-title":"Nature"},{"key":"7692_CR173","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature21049","volume":"541","author":"Z Erez","year":"2017","unstructured":"Erez Z, et al. Communication between viruses guides lysis-lysogeny decisions. Nature. 2017;541:488\u201393.","journal-title":"Nature"},{"key":"7692_CR174","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature17193","volume":"531","author":"B Knowles","year":"2016","unstructured":"Knowles B, et al. Lytic to temperate switching of viral communities. Nature. 2016;531:466\u201370.","journal-title":"Nature"},{"key":"7692_CR175","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.chom.2019.10.009","volume":"26","author":"AG Clooney","year":"2019","unstructured":"Clooney AG, et al. Whole-virome analysis Sheds Light on viral dark matter in inflammatory bowel disease. Cell Host Microbe. 2019;26:764\u201378.e5.","journal-title":"Cell Host Microbe"},{"key":"7692_CR176","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11262-022-01964-y","volume":"59","author":"J Cui","year":"2023","unstructured":"Cui J, et al. Whole genome sequencing and annotation of a lysogenic phage vB_ecop_de5 isolated from donkey-derived Escherichia coli. Virus Genes. 2023;59:290\u2013300.","journal-title":"Virus Genes"},{"key":"7692_CR177","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00284-010-9729-8","volume":"62","author":"Y Yan","year":"2011","unstructured":"Yan Y, et al. Prevalence of Stx phages in environments of a pig farm and lysogenic infection of the field E. coli O157 isolates with a recombinant converting phage. Curr Microbiol. 2011;62:458\u201364.","journal-title":"Curr Microbiol"},{"key":"7692_CR178","doi-asserted-by":"crossref","first-page":"e1011127","DOI":"10.1371\/journal.ppat.1011127","volume":"19","author":"P Misson","year":"2023","unstructured":"Misson P, et al. Phage production is blocked in the adherent-invasive Escherichia coli LF82 upon macrophage infection. PLoS Pathog. 2023;19:e1011127.","journal-title":"PLoS Pathog"},{"key":"7692_CR179","first-page":"2093","volume":"198","author":"J Pohar","year":"2017","unstructured":"Pohar J, et al. Selectivity of human TLR9 for Double CpG motifs and Implications for the recognition of genomic DNA. J Immunol Baltim Md 1950. 2017;198:2093\u2013104.","journal-title":"J Immunol Baltim Md 1950"},{"key":"7692_CR180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-virology-092917-043244","volume":"5","author":"Z Ma","year":"2018","unstructured":"Ma Z, Ni G, Damania B. Innate sensing of DNA virus genomes. Annu Rev Virol. 2018;5:341\u201362.","journal-title":"Annu Rev Virol"},{"key":"7692_CR181","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nature14138","volume":"520","author":"U Ohto","year":"2015","unstructured":"Ohto U, et al. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature. 2015;520:702\u201305.","journal-title":"Nature"},{"key":"7692_CR182","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.4049\/jimmunol.1001798","volume":"185","author":"JM Poth","year":"2010","unstructured":"Poth JM, et al. Monocyte-mediated inhibition of TLR9-dependent IFN-\u03b1 induction in plasmacytoid dendritic cells questions bacterial DNA as the active ingredient of bacterial lysates. J Immunol Baltim. Md 1950, 2010;185:7367\u201373.","journal-title":"J Immunol Baltim"},{"key":"7692_CR183","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-065X.2011.01048.x","volume":"243","author":"T Kawasaki","year":"2011","unstructured":"Kawasaki T, Kawai T, Akira S. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev. 2011;243:61\u201373.","journal-title":"Immunol Rev"},{"key":"7692_CR184","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1021\/acs.est.4c08265","volume":"59","author":"R Xia","year":"2025","unstructured":"Xia R, et al. Bacterium-phage symbiosis facilitates the enrichment of bacterial pathogens and antibiotic-resistant bacteria in the plastisphere. Environ Sci Technol. 2025;59:2948\u201360.","journal-title":"Environ Sci Technol"},{"key":"7692_CR185","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40168-022-01384-y","volume":"10","author":"X-Q Luo","year":"2022","unstructured":"Luo X-Q, et al. Viral community-wide auxiliary metabolic genes differ by lifestyles, habitats, and hosts. Microbiome. 2022;10:190.","journal-title":"Microbiome"},{"key":"7692_CR186","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tig.2024.04.011","volume":"40","author":"AK Szczepankowska","year":"2024","unstructured":"Szczepankowska AK, \u0141obocka M. Exploring the role of phage plasmids in gene transfers. Trends Genet TIG. 2024;40:555\u201357.","journal-title":"Trends Genet TIG"},{"key":"7692_CR187","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1038\/s41467-023-41075-2","volume":"14","author":"M Yan","year":"2023","unstructured":"Yan M, et al. Interrogating the viral dark matter of the rumen ecosystem with a global virome database. Nat Commun. 2023;14:5254.","journal-title":"Nat Commun"},{"key":"7692_CR188","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/ismej.2016.3","volume":"10","author":"J De Smet","year":"2016","unstructured":"De Smet J, et al. High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection. Isme J. 2016;10:1823\u201335.","journal-title":"Isme J"},{"key":"7692_CR189","doi-asserted-by":"crossref","first-page":"108142","DOI":"10.1016\/j.celrep.2020.108142","volume":"32","author":"DE Campbell","year":"2020","unstructured":"Campbell DE, et al. Infection with Bacteroides phage BV01 alters the host Transcriptome and bile acid metabolism in a common human gut Microbe. Cell Rep. 2020;32:108142.","journal-title":"Cell Rep"},{"key":"7692_CR190","doi-asserted-by":"crossref","first-page":"1382332","DOI":"10.3389\/fmicb.2024.1382332","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. The impact of antibiotic exposure on antibiotic resistance gene dynamics in the gut microbiota of inflammatory bowel disease patients. Front Microbiol. 2024;15:1382332.","journal-title":"Front Microbiol"},{"key":"7692_CR191","doi-asserted-by":"crossref","first-page":"963173","DOI":"10.3389\/fmicb.2023.963173","volume":"14","author":"E Pargin","year":"2023","unstructured":"Pargin E, et al. The human gut virome: composition, colonization, interactions, and impacts on human health. Front Microbiol. 2023;14:963173.","journal-title":"Front Microbiol"},{"key":"7692_CR192","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","volume":"152","author":"RB Sartor","year":"2017","unstructured":"Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic Approaches. Gastroenterology. 2017;152:327\u201339.e4.","journal-title":"Gastroenterology"},{"key":"7692_CR193","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/ijms21082668","volume":"21","author":"M Matija\u0161i\u0107","year":"2020","unstructured":"Matija\u0161i\u0107 M, et al. Gut microbiota beyond bacteria-mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int J Mol Sci. 2020;21:2668.","journal-title":"Int J Mol Sci"},{"key":"7692_CR194","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/microorganisms9020236","volume":"9","author":"L Aitmanait\u0117","year":"2021","unstructured":"Aitmanait\u0117 L, Konovalovas A, Medvedevas P, Servien\u0117 E, Serva S. Specificity determination in Saccharomyces cerevisiae killer Virus systems. Microorganisms. 2021;9:236.","journal-title":"Microorganisms"},{"key":"7692_CR195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/toxins9100333","volume":"9","author":"B Becker","year":"2017","unstructured":"Becker B, Schmitt MJ. Yeast killer toxin K28: biology and unique strategy of host cell intoxication and killing. Toxins. 2017;9:333.","journal-title":"Toxins"},{"key":"7692_CR196","doi-asserted-by":"crossref","first-page":"fow003","DOI":"10.1093\/femsyr\/fow003","volume":"16","author":"I Orentaite","year":"2016","unstructured":"Orentaite I, Poranen MM, Oksanen HM, Daugelavicius R, Bamford DH. K2 killer toxin-induced physiological changes in the yeast Saccharomyces cerevisiae. FEMS Yeast Res. 2016;16:fow003.","journal-title":"FEMS Yeast Res"},{"key":"7692_CR197","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/yea.3987","volume":"41","author":"A Chan","year":"2024","unstructured":"Chan A, Hays M, Sherlock G. The viral K1 killer yeast system: toxicity, immunity, and resistance. Yeast. 2024;41:668\u201380.","journal-title":"Yeast"},{"key":"7692_CR198","doi-asserted-by":"crossref","first-page":"e1005890","DOI":"10.1371\/journal.ppat.1005890","volume":"12","author":"PA Rowley","year":"2016","unstructured":"Rowley PA, Ho B, Bushong S, Johnson A, Sawyer SL. XRN1 is a species-specific Virus restriction factor in yeasts. PLoS Pathog. 2016;12:e1005890.","journal-title":"PLoS Pathog"},{"key":"7692_CR199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/gr1588","volume":"16","author":"A Thavamani","year":"2023","unstructured":"Thavamani A, Umapathi KK, Sferra TJ, Sankararaman S. Cytomegalovirus infection is associated with adverse outcomes among hospitalized pediatric patients with inflammatory bowel disease. Gastroenterol Res. 2023;16:1\u20138.","journal-title":"Gastroenterol Res"},{"key":"7692_CR200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00384-025-04886-x","volume":"40","author":"M Gholami Shahrebabak","year":"2025","unstructured":"Gholami Shahrebabak M, et al. Systematic review and meta-analysis of cytomegalovirus-associated adverse outcomes and healthcare resource utilization in hospitalized patients with inflammatory bowel disease. Int J Colorectal Dis. 2025;40:101.","journal-title":"Int J Colorectal Dis"},{"key":"7692_CR201","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v22.i3.1321","volume":"22","author":"TEH R\u00f6mkens","year":"2016","unstructured":"R\u00f6mkens TEH, Bulte GJ, Nissen LHC, Drenth JPH. Cytomegalovirus in inflammatory bowel disease: a systematic review. World J Gastroenterol. 2016;22:1321\u201330.","journal-title":"World J Gastroenterol"},{"key":"7692_CR202","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1\u2013106.","journal-title":"Gut"},{"key":"7692_CR203","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s10753-019-01122-x","volume":"43","author":"L Xuan","year":"2020","unstructured":"Xuan L, et al. Cytomegalovirus infection exacerbates experimental colitis by promoting IL-23 production. Inflammation. 2020;43:326\u201335.","journal-title":"Inflammation"},{"key":"7692_CR204","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s40168-022-01355-3","volume":"10","author":"N Chin","year":"2022","unstructured":"Chin N, et al. Cytomegalovirus infection disrupts the influence of short-chain fatty acid producers on Treg\/Th17 balance. Microbiome. 2022;10:168.","journal-title":"Microbiome"},{"key":"7692_CR205","doi-asserted-by":"crossref","first-page":"e00046","DOI":"10.1128\/mSystems.00046-21","volume":"6","author":"BW Wright","year":"2021","unstructured":"Wright BW, et al. Proteomic and transcriptomic analysis of microviridae \u03c6X174 infection reveals broad upregulation of host Escherichia coli membrane damage and heat shock responses. mSystems. 2021;6:e00046\u201321.","journal-title":"mSystems"},{"key":"7692_CR206","doi-asserted-by":"crossref","unstructured":"Harrison E, Brockhurst MA. Ecological and evolutionary benefits of temperate phage: what does or doesn\u2019t kill you makes you stronger. bioessays News Rev Mol Cell Dev Biol. 2017;39.","DOI":"10.1002\/bies.201700112"},{"key":"7692_CR207","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1136\/gutjnl-2019-320005","volume":"69","author":"TS Rasmussen","year":"2020","unstructured":"Rasmussen TS, et al. Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model. Gut. 2020;69:2122\u201330.","journal-title":"Gut"},{"key":"7692_CR208","doi-asserted-by":"crossref","first-page":"117065","DOI":"10.1016\/j.biopha.2024.117065","volume":"177","author":"C Zeng","year":"2024","unstructured":"Zeng C, et al. Fecal virome transplantation: a promising strategy for the treatment of metabolic diseases. Biomed Pharmacother Biomedecine Pharmacother. 2024;177:117065.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"7692_CR209","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12915-020-00906-0","volume":"18","author":"LA Draper","year":"2020","unstructured":"Draper LA, et al. Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbation. BMC Biol. 2020;18:173.","journal-title":"BMC Biol"},{"key":"7692_CR210","doi-asserted-by":"crossref","first-page":"123309","DOI":"10.1016\/j.lfs.2024.123309","volume":"361","author":"X Cheng","year":"2025","unstructured":"Cheng X, et al. Modulating intestinal viruses: a potential avenue for improving metabolic diseases with unresolved challenges. Life Sci. 2025;361:123309.","journal-title":"Life Sci"},{"key":"7692_CR211","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40168-024-01820-1","volume":"12","author":"TS Rasmussen","year":"2024","unstructured":"Rasmussen TS, et al. Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments. Microbiome. 2024;12:119.","journal-title":"Microbiome"},{"key":"7692_CR212","doi-asserted-by":"crossref","first-page":"103316","DOI":"10.1016\/j.psj.2023.103316","volume":"103","author":"D Wu","year":"2024","unstructured":"Wu D, et al. Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers. Poult Sci. 2024;103:103316.","journal-title":"Poult Sci"},{"key":"7692_CR213","doi-asserted-by":"crossref","first-page":"2208504","DOI":"10.1080\/19490976.2023.2208504","volume":"15","author":"TS Rasmussen","year":"2023","unstructured":"Rasmussen TS, et al. Fecal virome transfer improves proliferation of commensal gut Akkermansia muciniphila and unexpectedly enhances the fertility rate in laboratory mice. Gut Microbes. 2023;15:2208504.","journal-title":"Gut Microbes"},{"key":"7692_CR214","doi-asserted-by":"crossref","first-page":"1211271","DOI":"10.3389\/fmicb.2023.1211271","volume":"14","author":"C Huang","year":"2023","unstructured":"Huang C, Hao W, Wang X, Zhou R, Lin Q. Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022. Front Microbiol. 2023;14:1211271.","journal-title":"Front Microbiol"},{"key":"7692_CR215","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/nu12071973","volume":"12","author":"D Jakubczyk","year":"2020","unstructured":"Jakubczyk D, Leszczy\u0144ska K, G\u00f3rska S. The effectiveness of probiotics in the treatment of inflammatory bowel disease (IBD)-A critical review. Nutrients. 2020;12:1973.","journal-title":"Nutrients"},{"key":"7692_CR216","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3390\/biomedicines10092236","volume":"10","author":"J \u0160tofilov\u00e1","year":"2022","unstructured":"\u0160tofilov\u00e1 J, et al. Probiotic-based intervention in the treatment of ulcerative colitis: conventional and new approaches. Biomedicines. 2022;10:2236.","journal-title":"Biomedicines"},{"key":"7692_CR217","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/gutjnl-2019-319407","volume":"69","author":"SC Ng","year":"2020","unstructured":"Ng SC, et al. Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific association of Gastroenterology (APAGE) and Asia-Pacific Society for digestive endoscopy (APSDE). Gut. 2020;69:83\u201391.","journal-title":"Gut"},{"key":"7692_CR218","doi-asserted-by":"crossref","unstructured":"Zhang F, et al. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease. Nat Commun. 2021;12(65).","DOI":"10.1038\/s41467-020-20240-x"},{"key":"7692_CR219","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/apt.14173","volume":"46","author":"SP Costello","year":"2017","unstructured":"Costello SP, et al. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther. 2017;46:213\u201324.","journal-title":"Aliment Pharmacol Ther"},{"key":"7692_CR220","doi-asserted-by":"crossref","first-page":"802","DOI":"10.21037\/atm-22-3236","volume":"10","author":"Z-J Wei","year":"2022","unstructured":"Wei Z-J, Dong H-B, Ren Y-T, Jiang B. Efficacy and safety of fecal microbiota transplantation for the induction of remission in active ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials. Ann Transl Med. 2022;10:802.","journal-title":"Ann Transl Med"},{"key":"7692_CR221","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/biomedicines8080268","volume":"8","author":"D Ma\u0144kowska-Wierzbicka","year":"2020","unstructured":"Ma\u0144kowska-Wierzbicka D, et al. The effectiveness of multi-session FMT treatment in active ulcerative colitis patients: a pilot study. Biomedicines. 2020;8:268.","journal-title":"Biomedicines"},{"key":"7692_CR222","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10151-020-02395-3","volume":"25","author":"F Cheng","year":"2021","unstructured":"Cheng F, Huang Z, Wei W, Li Z. Fecal microbiota transplantation for Crohn\u2019s disease: a systematic review and meta-analysis. Tech Coloproctology. 2021;25:495\u2013504.","journal-title":"Tech Coloproctology"},{"key":"7692_CR223","doi-asserted-by":"crossref","unstructured":"Zhou S, Cui Y, Zhang Y, Zhao T, Cong J. Fecal microbiota transplantation for induction of remission in Crohn\u2019s disease: a systematic review and meta-analysis. Int J Colorectal Dis. 2023;38(62).","DOI":"10.1007\/s00384-023-04354-4"},{"key":"7692_CR224","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/jgh.15598","volume":"36","author":"SR Fehily","year":"2021","unstructured":"Fehily SR, Basnayake C, Wright EK, Kamm MA. Fecal microbiota transplantation therapy in Crohn\u2019s disease: systematic review. J Gastroenterol Hepatol. 2021;36:2672\u201386.","journal-title":"J Gastroenterol Hepatol"},{"key":"7692_CR225","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1053\/j.gastro.2020.08.045","volume":"159","author":"L Kong","year":"2020","unstructured":"Kong L, et al. Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn\u2019s disease. Gastroenterology. 2020;159:2193\u2013202.e5.","journal-title":"Gastroenterology"},{"key":"7692_CR226","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41591-024-03280-4","volume":"30","author":"J Zheng","year":"2024","unstructured":"Zheng J, et al. Noninvasive, microbiome-based diagnosis of inflammatory bowel disease. Nat Med. 2024;30:3555\u201367.","journal-title":"Nat Med"},{"key":"7692_CR227","doi-asserted-by":"crossref","first-page":"2205386","DOI":"10.1080\/19490976.2023.2205386","volume":"15","author":"M Li","year":"2023","unstructured":"Li M, et al. Performance of gut microbiome as an Independent diagnostic tool for 20 diseases: cross-cohort validation of machine-learning classifiers. Gut Microbes. 2023;15:2205386.","journal-title":"Gut Microbes"},{"key":"7692_CR228","doi-asserted-by":"crossref","unstructured":"Serrano-G\u00f3mez G, et al. Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology. Biomark Res. 2025;13(85).","DOI":"10.1186\/s40364-025-00802-1"},{"key":"7692_CR229","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/s41598-025-90160-7","volume":"15","author":"JE Kim","year":"2025","unstructured":"Kim JE, et al. Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profiling. Sci Rep. 2025;15:5661.","journal-title":"Sci Rep"},{"key":"7692_CR230","doi-asserted-by":"crossref","unstructured":"Avershina E, Qureshi AI, Winther-Larsen HC, Rounge TB. Challenges in capturing the mycobiome from shotgun metagenome data: lack of software and databases. Microbiome. 2025;13(66).","DOI":"10.1186\/s40168-025-02048-3"},{"key":"7692_CR231","doi-asserted-by":"crossref","first-page":"10291","DOI":"10.1038\/s41467-024-54797-8","volume":"15","author":"S Akiyama","year":"2024","unstructured":"Akiyama S, et al. Multi-biome analysis identifies distinct gut microbial signatures and their crosstalk in ulcerative colitis and Crohn\u2019s disease. Nat Commun. 2024;15:10291.","journal-title":"Nat Commun"},{"key":"7692_CR232","doi-asserted-by":"crossref","first-page":"127660","DOI":"10.1016\/j.micres.2024.127660","volume":"282","author":"C Wang","year":"2024","unstructured":"Wang C, et al. Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: a comprehensive systematic review. Microbiol Res. 2024;282:127660.","journal-title":"Microbiol Res"},{"key":"7692_CR233","doi-asserted-by":"crossref","first-page":"2391505","DOI":"10.1080\/19490976.2024.2391505","volume":"16","author":"FM Prins","year":"2024","unstructured":"Prins FM, et al. Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease. Gut Microbes. 2024;16:2391505.","journal-title":"Gut Microbes"},{"key":"7692_CR234","doi-asserted-by":"crossref","first-page":"2287073","DOI":"10.1080\/19490976.2023.2287073","volume":"15","author":"S Meade","year":"2023","unstructured":"Meade S, et al. Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review. Gut Microbes. 2023;15:2287073.","journal-title":"Gut Microbes"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07692-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:09:19Z","timestamp":1774973359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07692-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7692"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07692-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a review based on previously published studies. It does not involve any new studies with human participants or animals performed by any of the authors. Therefore, ethics approval and consent to participate are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"456"}}